| Title : FAP-Inhibitor Homodimers with Engineered Linker-Spacer Units: Toward Optimized Radiopharmaceuticals - Kumar_2026_ACS.Omega_11_49001 |
| Author(s) : Kumar N , Martin M , Bilinska A , Menendez E , De Meester I , Roesch F , Rominger A , Gourni E |
| Ref : ACS Omega , 11 :49001 , 2026 |
| Abstract : |
| PubMedSearch : Kumar_2026_ACS.Omega_11_49001 |
| PubMedID: 42662658 |
| Title : Preclinical evaluation of DOTAGA.Glu.(FAPI)(2) and DO3A.Glu.(FAPI)(2) as theranostics with human dosimetry extrapolation to lutetium-177 and terbium-161 analogs - Bilinska_2026_Eur.J.Nucl.Med.Mol.Imaging_53_1887 |
| Author(s) : Bilinska A , Kumar N , Gnesin S , Lappchen T , Menendez E , Martin M , Rosch F , Rominger A , Gourni E |
| Ref : Eur J Nucl Med Mol Imaging , 53 :1887 , 2026 |
| Abstract : |
| PubMedSearch : Bilinska_2026_Eur.J.Nucl.Med.Mol.Imaging_53_1887 |
| PubMedID: 41105225 |
| Title : Tailoring Fibroblast-Activation Protein Targeting for Theranostics: A Comparative Preclinical Evaluation of the (68)Ga- and (177)Lu-Labeled Monomeric and Dimeric Fibroblast-Activation Protein Inhibitors DOTA.SA.FAPi and DOTAGA.(SA.FAPi)(2) - Lappchen_2024_Molecules_29_ |
| Author(s) : Lappchen T , Bilinska A , Pilatis E , Menendez E , Imlimthan S , Moon ES , Afshar-Oromieh A , Rosch F , Rominger A , Gourni E |
| Ref : Molecules , 29 : , 2024 |
| Abstract : |
| PubMedSearch : Lappchen_2024_Molecules_29_ |
| PubMedID: 38999044 |
| Title : Translational assessment of a DATA-functionalized FAP inhibitor with facile (68)Ga-labeling at room temperature - Escudero-Castellanos_2023_Eur.J.Nucl.Med.Mol.Imaging_50_3202 |
| Author(s) : Escudero-Castellanos A , Kurth J , Imlimthan S , Menendez E , Pilatis E , Moon ES , Lappchen T , Rathke H , Schwarzenbock SM , Krause BJ , Rosch F , Rominger A , Gourni E |
| Ref : Eur J Nucl Med Mol Imaging , 50 :3202 , 2023 |
| Abstract : |
| PubMedSearch : Escudero-Castellanos_2023_Eur.J.Nucl.Med.Mol.Imaging_50_3202 |
| PubMedID: 37284857 |
| Title : New Frontiers in Cancer Imaging and Therapy Based on Radiolabeled Fibroblast Activation Protein Inhibitors: A Rational Review and Current Progress - Imlimthan_2021_Pharmaceuticals.(Basel)_14_ |
| Author(s) : Imlimthan S , Moon ES , Rathke H , Afshar-Oromieh A , Rosch F , Rominger A , Gourni E |
| Ref : Pharmaceuticals (Basel) , 14 : , 2021 |
| Abstract : |
| PubMedSearch : Imlimthan_2021_Pharmaceuticals.(Basel)_14_ |
| PubMedID: 34681246 |
| Gene_locus related to this paper: human-FAP |